Cargando…
Induced Pluripotent Stem Cell for the Study and Treatment of Sickle Cell Anemia
Sickle cell anemia (SCA) is a monogenic disease of high mortality, affecting millions of people worldwide. There is no broad, effective, and safe definitive treatment for SCA, so the palliative treatments are the most used. The establishment of an in vitro model allows better understanding of how th...
Autores principales: | Junqueira Reis, Luiza Cunha, Picanço-Castro, Virgínia, Paes, Bárbara Cristina Martins Fernandes, Pereira, Olívia Ambrozini, Gerdes Gyuricza, Isabela, de Araújo, Fabiano Tófoli, Morato-Marques, Mariana, Moreira, Lílian Figueiredo, Costa, Everton de Brito Oliveira, dos Santos, Tálita Pollyanna Moreira, Covas, Dimas Tadeu, Pereira Carramaschi, Lygia da Veiga, Russo, Elisa Maria de Sousa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549510/ https://www.ncbi.nlm.nih.gov/pubmed/28814957 http://dx.doi.org/10.1155/2017/7492914 |
Ejemplares similares
-
Is HSPG2 a modifier gene for Marfan syndrome?
por: Gerdes Gyuricza, Isabela, et al.
Publicado: (2020) -
Generation of hematopoietic stem/progenitor cells with sickle cell mutation from induced pluripotent stem cell in serum-free system
por: Paes, Bárbara C.M.F., et al.
Publicado: (2021) -
Microfluidics in Sickle Cell Disease Research: State of the Art and a Perspective Beyond the Flow Problem
por: Aich, Anupam, et al.
Publicado: (2021) -
Mobilizing hematopoietic progenitor cells in donors with sickle cell trait is safe
por: De Santis, Gil Cunha, et al.
Publicado: (2019) -
Increasing The Genetic Admixture of Available Lines of Human Pluripotent Stem Cells
por: Tofoli, Fabiano A., et al.
Publicado: (2016)